Bionet (1784) — Cash Flow Quality Index
Latest as of June 2026:
2.59x
Bionet (1784) has a Cash Flow Quality Index of 2.59x as of June 2026. Operating cash flow of NT$51.22 Million exceeds net income of NT$19.80 Million, indicating high earnings quality where cash backs reported profits. Explore how well can Bionet service its debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
2.59x
Operating CF / Net Income
Operating Cash Flow
NT$51.22 Million
TWD
Net Income
NT$19.80 Million
TWD
Data as of
Jun 2026
Most recent filing
Bionet Cash Flow Quality Index (2018–2025)
Historical Cash Flow Quality Index for Bionet across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 1784 cash generation efficiency.
Annual Cash Flow Quality Index for Bionet (2018–2025)
Year-by-year earnings quality comparison for Bionet.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | NT$148.04 Million | NT$51.43 Million | ▲ +36.5% |
| 2024 | 2.11x | NT$176.49 Million | NT$83.70 Million | ▲ +47.5% |
| 2023 | 1.43x | NT$153.09 Million | NT$107.08 Million | ▼ -42.6% |
| 2022 | 2.49x | NT$94.65 Million | NT$37.97 Million | ▲ +639.8% |
| 2021 | 0.34x | NT$13.88 Million | NT$41.19 Million | ▼ -97.1% |
| 2020 | 11.47x | NT$73.66 Million | NT$6.42 Million | ▲ +2823.6% |
| 2019 | 0.39x | NT$2.67 Million | NT$6.80 Million | ▲ +173.3% |
| 2018 | -0.54x | NT$-12.97 Million | NT$24.23 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.